Abstract：ObjectiveTo compare the efficacy and safety of tacrolimus and leflunomide in the treatment of idiopathic membranous nephropathy.Methods80 patients with membranous nephropathy treated in our hospital from June 2015 to January 2017 were selected as the subjects,and divided into control group and observation group according to random data table method,40 cases in each group.All patients were treated with prednisone regularly.In addition,patients in the control group were treated with leflunomide,and patients in the observation group were treated with tacrolimus,6 months for a course of treatment.The difference of clinical efficacy between the two groups was compared.ResultsAfter treatment,the renal function indexes such as 24 h urinary protein and serum creatinine in the observation group were lower than those in the control group,the difference was statistically significant(P＜0.05).Triglyceride (TG),total cholesterol(TC)and other blood lipid levels in the observation group were lower than those in the control group,the difference was statistically significant(P＜0.05).The total effective rate of the observation group (77.50%)was higher than that of the control group (55.00%),the difference was statistically significant(P＜0.05).The total incidence of adverse reactions in the observation group(30.00%)was higher than that of the control group(13.33%),the difference was statistically significant (P＜0.05).ConclusionFor leflunomide,tacrolimus is more effective in the treatment of idiopathic membranous nephropathy.Tacrolimus can effectively improve renal function and blood lipid levels,safe and reliable,which is worthy of promotion.
王天祺;杨颖达. 他克莫司与来氟米特治疗特发性膜性肾病的效果及安全性对比[J]. 中国当代医药, 2018, 25(2): 138-140转144.
WANG Tian-qi;YANG Ying-da. Comparison of efficacy and safety between tacrolimus and leflunomide in the treatment of idiopathic membranous nephropathy. 中国当代医药, 2018, 25(2): 138-140转144.
京公网安备 11010502046607号